Y-Intercept (HK)’s Xenon Pharmaceuticals XENE Stock Holding History

Y-Intercept (HK)’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.16M	Buy	+57,973	New	+$3.44M	0.05%	593
2026 Q2	–	Sell	-85,388	Closed	-$4.97M	–	2231
2026 Q1	$4.97M	Buy	85,388 +12,431	+17%	+$573K	0.09%	321
2025 Q4	$3.27M	Buy	+72,957	New	+$3.06M	0.07%	388
2025 Q2	–	Sell	-11,949	Closed	-$401K	–	2071
2025 Q1	$401K	Buy	+11,949	New	+$454K	0.03%	796
2024 Q4	–	Sell	-24,557	Closed	-$967K	–	1722
2024 Q3	$967K	Buy	24,557 +10,007	+69%	+$403K	0.06%	459
2024 Q2	$567K	Sell	14,550 -3,755	-21%	-$150K	0.03%	758
2024 Q1	$788K	Buy	+18,305	New	+$842K	0.06%	488
2022 Q3	–	Sell	-7,324	Closed	-$223K	–	1318
2022 Q2	$223K	Buy	+7,324	New	+$222K	0.03%	653

Other funds holding XENE

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Elmwood Wealth Management Berkeley, California $416M AUM 11.87% 1-Year Est. Return

Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Harbor Investment Advisory Lutherville, Maryland $1.47B AUM 24.2% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Y-Intercept (HK)'s XENE Position: Q3 2026 in Review

Y-Intercept (HK) opened a new position in Xenon Pharmaceuticals (XENE) in Q3 2026: 57,973 shares worth $2.16M. The stake represents 0.05% of the portfolio and ranks #593 among its holdings. This is a return to the name: Y-Intercept (HK) previously reported a position in XENE as recently as Q1 2026.

Y-Intercept (HK) first reported a position in XENE in Q2 2022 and has held it in 8 quarters since. The position peaked at $4.97M in Q1 2026. 20 funds tracked by Wall St. Rank hold XENE as of Q3 2026.

Y-Intercept (HK) held 57,973 shares of Xenon Pharmaceuticals worth $2.16M as of Q3 2026.
Xenon Pharmaceuticals was a new Y-Intercept (HK) position in Q3 2026.
Xenon Pharmaceuticals made up 0.05% of Y-Intercept (HK)'s portfolio in Q3 2026, its #593 holding.
Y-Intercept (HK) first reported a position in Xenon Pharmaceuticals in Q2 2022 and has held it in 8 quarters since.
Y-Intercept (HK)'s Xenon Pharmaceuticals position peaked at $4.97M in Q1 2026.
20 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.